Global burden of multiple sclerosis and its attributable risk factors, 1990-2019

被引:2
|
作者
Safiri, Saeid [1 ,2 ]
Jolfayi, Amir Ghaffari [1 ]
Mousavi, Seyed Ehsan [3 ]
Nejadghaderi, Seyed Aria [4 ,5 ,6 ]
Sullman, Mark J. M. [7 ,8 ]
Kolahi, Ali-Asghar [9 ]
机构
[1] Tabriz Univ Med Sci, Aging Res Inst, Neurosci Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Clin Res Dev Unit, Tabriz Valiasr Hosp, Tabriz, Iran
[3] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran
[4] Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr, Kerman, Iran
[5] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran
[6] Universal Sci Educ & Res Network USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Tehran, Iran
[7] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus
[8] Univ Nicosia, Dept Social Sci, Nicosia, Cyprus
[9] Shahid Beheshti Univ Med Sci, Social Determinants Hlth Res Ctr, Tehran, Iran
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
multiple sclerosis; death; prevalence; disability adjusted life years; global; SEX;
D O I
10.3389/fneur.2024.1448377
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Multiple sclerosis (MS) is a progressively debilitating disorder that has seen a notable rise in prevalence in recent years. This study examines the burden of MS from 1990 to 2019, providing a detailed analysis by age, sex, and sociodemographic index (SDI) across 204 countries and territories.Methods Data on the prevalence, death and disability-adjusted life years (DALYs) attributable to MS were obtained from the publically available Global Burden of Disease 2019 project. The estimates are reported as numbers, percentages, and age-standardized rates per 100,000, accompanied by 95% uncertainty intervals.Results In 2019, MS accounted for 1.8 million prevalent cases, 22.4 thousand deaths and 1.2 million DALYs worldwide. There were significant declines in the global age-standardized prevalence, mortality and DALY rates of MS over the period 1990-2019. In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. At the regional level, a non-linear relationship was observed between the age-standardized DALY rate of MS and SDI.Conclusion Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. Integrating MS and its associated risk factors into healthcare planning is vital, especially in areas with high levels of socioeconomic development.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Stroke burden and attributable risk factors in China, 1990-2019
    Tian, Wenxin
    Zhu, Guanghan
    Xiao, Wenbo
    Gao, Bei
    Lu, Wenli
    Wang, Yuan
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [2] The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035
    Song, Yexun
    Cheng, Wenwei
    Li, Heqing
    Liu, Xiajing
    CANCER MEDICINE, 2022, 11 (22): : 4310 - 4320
  • [3] The global, regional, national burden of laryngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035
    Lin, Changwei
    Cheng, Wenwei
    Liu, Xiajing
    Li, Heqing
    Song, Yexun
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [4] Cancer burden attributable to risk factors, 1990-2019: A comparative risk assessment
    Hu, Junjie
    Dong, Hongliang
    Dong, Yiming
    Zhou, Runxuan
    Teixeira, Wilhem
    He, Xingxing
    Ye, Da-Wei
    Ti, Gang
    ISCIENCE, 2024, 27 (04)
  • [5] Global, regional, and national burden and attributable risk factors of transport injuries: Global Burden of Disease Study 1990-2019
    Chen, Fa
    Wu, Yuxuan
    Chen, Xiangrong
    Chen, Yue
    Chen, Xiaoyong
    Wu, Yuying
    Wei, Penghui
    Kang, Dezhi
    Ding, Chenyu
    CHINESE MEDICAL JOURNAL, 2023, 136 (14) : 1762 - 1764
  • [6] Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019
    Ding, Chenyu
    Wu, Yuying
    Chen, Xiaoyong
    Chen, Yue
    Wu, Zanyi
    Lin, Zhangya
    Kang, Dezhi
    Fang, Wenhua
    Chen, Fa
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [7] Global, regional and national burden of lung cancer and its attributable risk factors in 204 countries and territories, 1990-2019
    Yuan, Jingmin
    Sun, Yan
    Bu, Xiang
    Ren, Hui
    Chen, Mingwei
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2022, 31 (03) : 253 - 259
  • [8] The global, regional, and national burden of nasopharyngeal carcinoma and its attributable risk factors in 204 countries and territories, 1990-2019
    Zhang, Yuna
    Cao, Yujie
    Luo, Lin
    Li, Jun
    Wang, Liuqian
    Lu, Yaqin
    Gu, Shanshan
    Deng, Hongxia
    Shen, Zhisen
    ACTA OTO-LARYNGOLOGICA, 2022, 142 (7-8) : 590 - 609
  • [9] Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019
    Ma, Qingfeng
    Li, Rui
    Wang, Lijun
    Yin, Peng
    Wang, Yuan
    Yan, Chuming
    Ren, Yi
    Qian, Zhengmin
    Vaughn, Michael G.
    McMillin, Stephen Edward
    Hay, Simon, I
    Naghavi, Mohsen
    Cai, Miao
    Wang, Chongjian
    Zhang, Zilong
    Zhou, Maigeng
    Lin, Hualiang
    Yang, Yin
    LANCET PUBLIC HEALTH, 2021, 6 (12): : E897 - E906
  • [10] Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019
    Zi, Hao
    He, Shao-Hua
    Leng, Xie-Yuan
    Xu, Xiao-Feng
    Huang, Qiao
    Weng, Hong
    Zhu, Cong
    Li, Lu-Yao
    Gu, Jia-Min
    Li, Xu-Hui
    Ming, Dao-Jing
    Li, Xiao-Dong
    Yuan, Shuai
    Wang, Xing-Huan
    He, Da-Lin
    Zeng, Xian-Tao
    MILITARY MEDICAL RESEARCH, 2021, 8 (01)